Reprogram or reboot: Small molecule approaches for the production of induced pluripotent stem cells and direct cell reprogramming

ACS Chemical Biology

Volumn 9, Issue 1, 2014, Pages 80-95

  Jung, Da Woon ^a   Kim, Woong Hee ^a   Williams, Darren Reece ^a  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; AURORA A KINASE; CALCIUM CHANNEL L TYPE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1; DNA METHYLTRANSFERASE; FORSKOLIN; GLYCOGEN SYNTHASE KINASE 3BETA; HISTONE METHYLTRANSFERASE; KRUPPEL LIKE FACTOR 4; LIVER RECEPTOR HOMOLOG 1; LUTEOLIN; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; RHO KINASE; TRANSCRIPTION FACTOR 3; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UVOMORULIN;

ANAEROBIC GLYCOLYSIS; CARCINOGENICITY; CELL AGING; CELL PROLIFERATION; CELL STRUCTURE; CELL TRANSDIFFERENTIATION; CYTOSKELETON; DEACETYLATION; DNA METHYLATION; DOUBLE STRANDED DNA BREAK; EMBRYONIC STEM CELL; ENZYME ACTIVATION; EPIGENETICS; GENETIC MANIPULATION; HEART MUSCLE CELL; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; MOLECULAR INTERACTION; NERVE CELL; NONHUMAN; NUCLEAR REPROGRAMMING; OXIDATIVE PHOSPHORYLATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; SOMATIC CELL; STEM CELL RESEARCH; UPREGULATION; WNT SIGNALING PATHWAY;

EID: 84990232162     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb400754     Document Type: Review

References (113)

1. Atkins, H. L., and Freedman, M. S. (2013) Hematopoietic stem cell therapy for multiple sclerosis: Top 10 lessons learned. Neurotherapeutics 10, 68-76.
2. Patil, S., and Schwarer, T. (2009) Natural killer cells-new understanding of basic biology may lead to more effective allogeneic haematopoietic stem cell transplantation. Intern. Med. J. 39, 639-647.
3. Remberger, M., Ackefors, M., Berglund, S., Blennow, O., Dahllof, G., Dlugosz, A., Garming-Legert, K., Gertow, J., Gustafsson, B., Hassan, M., Hassan, Z., Hauzenberger, D., Hagglund, H., Karlsson, H., Klingspor, L., Kumlien, G., Le Blanc, K., Ljungman, P., Machaczka, M., Malmberg, K. J., Marschall, H. U., Mattsson, J., Olsson, R., Omazic, B., Sairafi, D., Schaffer, M., Svahn, B. M., Svenberg, P., Swartling, L., Szakos, A., Uhlin, M., Uzunel, M., Watz, E., Wernerson, A., Wikman, A., Wikstrom, A. C., Winiarski, J., and Ringden, O. (2011) Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center study. Biol. Blood Marrow Transplant. 17, 1688-1697.
4. Tyndall, A., Fassas, A., Passweg, J., Ruiz de Elvira, C., Attal, M., Brooks, P., Black, C., Durez, P., Finke, J., Forman, S., Fouillard, L., Furst, D., Holmes, J., Joske, D., Jouet, J., Kotter, I., Locatelli, F., Prentice, H., Marmont, A. M., McSweeney, P., Musso, M., Peter, H. H., Snowden, J. A., Sullivan, K., Gratwohl, A., Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism, and International Stem Cell Project for Autoimmune Disease (1999) Autologous haematopoietic stem cell transplants for autoimmune disease-feasibility and transplant-related mortality. Bone Marrow Transplant. 24, 729-734. (Pubitemid 29469272)
5. de Wert, G., and Mummery, C. (2003) Human embryonic stem cells: Research, ethics and policy. Hum. Reprod. 18, 672-682. (Pubitemid 36426942)
6. Takahashi, K., and Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676. (Pubitemid 44233629)
7. Newman, A. M., and Cooper, J. B. (2010) Lab-specific gene expression signatures in pluripotent stem cells. Cell Stem Cell 7, 258-262.
8. Okano, H., Nakamura, M., Yoshida, K., Okada, Y., Tsuji, O., Nori, S., Ikeda, E., Yamanaka, S., and Miura, K. (2013) Steps toward safe cell therapy using induced pluripotent stem cells. Circ. Res. 112, 523-533.
9. Tanabe, K., Nakamura, M., Narita, M., Takahashi, K., and Yamanaka, S. (2013) Maturation, not initiation, is the major roadblock during reprogramming toward pluripotency from human fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 110, 12172-12179.
10. Nam, T. G., McNamara, C. W., Bopp, S., Dharia, N. V., Meister, S., Bonamy, G. M., Plouffe, D. M., Kato, N., McCormack, S., Bursulaya, B., Ke, H., Vaidya, A. B., Schultz, P. G., and Winzeler, E. A. (2011) A chemical genomic analysis of decoquinate, a Plasmodium falciparum cytochrome b inhibitor. ACS Chem. Biol. 6, 1214-1222.
11. Dougherty, T. J., Pucci, M. J., and Macielag, M. (2012) Chemical Properties of Antimicrobials and Their Uniqueness, Antibiotic Discovery and Development, pp 793-820, Springer: New York.
12. Lipinski, C. A. (2004) Lead-And drug-like compounds: The ruleof-five revolution. Drug Discovery Today: Technol. 1, 337-341. (Pubitemid 40186335)
13. Xu, Y., Shi, Y., and Ding, S. (2008) A chemical approach to stemcell biology and regenerative medicine. Nature 453, 338-344. (Pubitemid 351693140)
14. Li, W., Jiang, K., and Ding, S. (2013) Concise review: A chemical approach to control cell fate and function. Stem Cells 30, 61-68.
15. Li, W., and Ding, S. (2010) Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming. Trends Pharmacol. Sci. 31, 36-45.
16. Bao, X., Zhu, X., Liao, B., Benda, C., Zhuang, Q., Pei, D., Qin, B., and Esteban, M. A. (2013) MicroRNAs in somatic cell reprogramming. Curr. Opin. Cell Biol. 25, 208-214.
17. Banito, A., Rashid, S. T., Acosta, J. C., Li, S., Pereira, C. F., Geti, I., Pinho, S., Silva, J. C., Azuara, V., Walsh, M., Vallier, L., and Gil, J. (2009) Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev. 23, 2134-2139.
18. Wang, P., and Na, J. (2013) Reprogramming to pluripotency and differentiation of cells with synthetic mRNA. Methods Mol. Biol. 969, 221-233.
19. Rabinovich, P. M., and Weissman, S. M. (2013) Cell engineering with synthetic messenger RNA. Methods Mol. Biol. 969, 3-28.
20. Anastasia, L., Pelissero, G., Venerando, B., and Tettamanti, G. (2010) Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine. Cell Death Differ. 17, 1230-1237.
21. Wang, P., and Na, J. (2011) Mechanism and methods to induce pluripotency. Protein Cell 2, 792-799.
22. Lin, T., Ambasudhan, R., Yuan, X., Li, W., Hilcove, S., Abujarour, R., Lin, X., Hahm, H. S., Hao, E., Hayek, A., and Ding, S. (2009) A chemical platform for improved induction of human iPSCs. Nat. Methods 6, 805-808.
23. Li, R., Liang, J., Ni, S., Zhou, T., Qing, X., Li, H., He, W., Chen, J., Li, F., Zhuang, Q., Qin, B., Xu, J., Li, W., Yang, J., Gan, Y., Qin, D., Feng, S., Song, H., Yang, D., Zhang, B., Zeng, L., Lai, L., Esteban, M. A., and Pei, D. (2010) A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 7, 51-63.
24. Carver, E. A., Jiang, R., Lan, Y., Oram, K. F., and Gridley, T. (2001) The mouse snail gene encodes a key regulator of the epithelialmesenchymal transition. Mol. Cell. Biol. 21, 8184-8188. (Pubitemid 33051806)
25. Burdsal, C. A., Damsky, C. H., and Pedersen, R. A. (1993) The role of E-cadherin and integrins in mesoderm differentiation and migration at the mammalian primitive streak. Development 118, 829-844. (Pubitemid 23232790)
26. Samavarchi-Tehrani, P., Golipour, A., David, L., Sung, H. K., Beyer, T. A., Datti, A., Woltjen, K., Nagy, A., and Wrana, J. L. (2010) Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 7, 64-77.
27. Chen, T., Yuan, D., Wei, B., Jiang, J., Kang, J., Ling, K., Gu, Y., Li, J., Xiao, L., and Pei, G. (2010) E-cadherin-mediated cell-cell contact is critical for induced pluripotent stem cell generation. Stem Cells 28, 1315-1325.
28. Ichida, J. K., Blanchard, J., Lam, K., Son, E. Y., Chung, J. E., Egli, D., Loh, K. M., Carter, A. C., Di Giorgio, F. P., Koszka, K., Huangfu, D., Akutsu, H., Liu, D. R., Rubin, L. L., and Eggan, K. (2009) A smallmolecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell 5, 491-503.
29. Hou, P., Li, Y., Zhang, X., Liu, C., Guan, J., Li, H., Zhao, T., Ye, J., Yang, W., Liu, K., Ge, J., Xu, J., Zhang, Q., Zhao, Y., and Deng, H. (2013) Pluripotent stem cells induced from mouse somatic cells by smallmolecule compounds. Science 341, 651-654.
30. Chen, S., Takanashi, S., Zhang, Q., Xiong, W., Zhu, S., Peters, E. C., Ding, S., and Schultz, P. G. (2007) Reversine increases the plasticity of lineage-committed mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 104, 10482-10487. (Pubitemid 47185691)
31. Shimizu, T., Ueda, J., Ho, J. C., Iwasaki, K., Poellinger, L., Harada, I., and Sawada, Y. (2012) Dual inhibition of Src and GSK3 maintains mouse embryonic stem cells, whose differentiation is mechanically regulated by Src signaling. Stem Cells 30, 1394-1404.
32. Ficz, G., Hore, T. A., Santos, F., Lee, H. J., Dean, W., Arand, J., Krueger, F., Oxley, D., Paul, Y. L., Walter, J., Cook, S. J., Andrews, S., Branco, M. R., and Reik, W. (2013) FGF signaling inhibition in ESCs drives rapid genome-wide demethylation to the epigenetic ground state of pluripotency. Cell Stem Cell 13, 351-359.
33. Li, Z., and Rana, T. M. (2012) A kinase inhibitor screen identifies small-molecule enhancers of reprogramming and iPS cell generation. Nat. Commun. 3, 1085.
34. Taylor, S. S., Zhang, P., Steichen, J. M., Keshwani, M. M., and Kornev, A. P. (2013) PKA: Lessons learned after twenty years. Biochim. Biophys. Acta 1834, 1271-1278.
35. Faherty, S., Fitzgerald, A., Keohan, M., and Quinlan, L. R. (2007) Self-renewal and differentiation of mouse embryonic stem cells as measured by Oct4 expression: The role of the cAMP/PKA pathway. In Vitro Cell. Dev. Biol.: Anim. 43, 37-47. (Pubitemid 47087328)
36. Wang, Y., and Adjaye, J. (2011) A cyclic AMP analog, 8-Br-cAMP, enhances the induction of pluripotency in human fibroblast cells. Stem Cell Rev. 7, 331-341.
37. Zhu, S., Li, W., Zhou, H., Wei, W., Ambasudhan, R., Lin, T., Kim, J., Zhang, K., and Ding, S. (2010) Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 7, 651-655.
38. Maiese, K., Chong, Z. Z., Shang, Y. C., and Wang, S. (2012) Targeting disease through novel pathways of apoptosis and autophagy. Expert Opin. Ther. Targets 16, 1203-1214.
39. Okkenhaug, K. (2013) Signaling by the phosphoinositide 3-kinase family in immune cells. Annu. Rev. Immunol. 31, 675-704.
40. Dalton, S. (2013) Signaling networks in human pluripotent stem cells. Curr. Opin. Cell Biol. 25, 241-246.
41. Xu, X., Duan, S., Yi, F., Ocampo, A., Liu, G. H., and Izpisua Belmonte, J. C. (2013) Mitochondrial regulation in pluripotent stem cells. Cell Metab. 18, 325-332.
42. Li, W., Zhou, H., Abujarour, R., Zhu, S., Young Joo, J., Lin, T., Hao, E., Scholer, H. R., Hayek, A., and Ding, S. (2009) Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells 27, 2992-3000.
43. van Amerongen, R., and Nusse, R. (2009) Towards an integrated view of Wnt signaling in development. Development 136, 3205-3214.
44. Kim, W., Kim, M., and Jho, E. H. (2013) Wnt/beta-catenin signalling: From plasma membrane to nucleus. Biochem. J. 450, 9-21.
45. Niwa, H. (2011) Wnt: Whats needed to maintain pluripotency? Nat. Cell Biol. 13, 1024-1026.
46. Reya, T., and Clevers, H. (2005) Wnt signalling in stem cells and cancer. Nature 434, 843-850. (Pubitemid 40558990)
47. Giet, R., and Prigent, C. (1999) Aurora/Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases. J. Cell Sci. 112 (Pt 21), 3591-3601. (Pubitemid 129783931)
48. Amabile, G., DAlise, A. M., Iovino, M., Jones, P., Santaguida, S., Musacchio, A., Taylor, S., and Cortese, R. (2009) The Aurora B kinase activity is required for the maintenance of the differentiated state of murine myoblasts. Cell Death Differ. 16, 321-330.
49. Amanchy, R., Zhong, J., Molina, H., Chaerkady, R., Iwahori, A., Kalume, D. E., Gronborg, M., Joore, J., Cope, L., and Pandey, A. (2008) Identification of c-Src tyrosine kinase substrates using mass spectrometry and peptide microarrays. J. Proteome Res. 7, 3900-3910.
50. Staerk, J., Lyssiotis, C. A., Medeiro, L. A., Bollong, M., Foreman, R. K., Zhu, S., Garcia, M., Gao, Q., Bouchez, L. C., Lairson, L. L., Charette, B. D., Supekova, L., Janes, J., Brinker, A., Cho, C. Y., Jaenisch, R., and Schultz, P. G. (2011) Pan-Src family kinase inhibitors replace Sox2 during the direct reprogramming of somatic cells. Angew. Chem., Int. Ed. 50, 5734-5736.
51. Zweigerdt, R., Olmer, R., Singh, H., Haverich, A., and Martin, U. (2011) Scalable expansion of human pluripotent stem cells in suspension culture. Nat. Protoc. 6, 689-700.
52. Olmer, R., Haase, A., Merkert, S., Cui, W., Palecek, J., Ran, C., Kirschning, A., Scheper, T., Glage, S., Miller, K., Curnow, E. C., Hayes, E. S., and Martin, U. (2010) Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. Stem Cell Res. 5, 51-64.
53. Park, I. H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., and Daley, G. Q. (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141-146.
54. Tsutsui, H., Valamehr, B., Hindoyan, A., Qiao, R., Ding, X., Guo, S., Witte, O. N., Liu, X., Ho, C. M., and Wu, H. (2011) An optimized small molecule inhibitor cocktail supports long-term maintenance of human embryonic stem cells. Nat. Commun. 2, 167.
55. Heng, J. C., Feng, B., Han, J., Jiang, J., Kraus, P., Ng, J. H., Orlov, Y. L., Huss, M., Yang, L., Lufkin, T., Lim, B., and Ng, H. H. (2010) The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell 6, 167-174.
56. Wang, W., Yang, J., Liu, H., Lu, D., Chen, X., Zenonos, Z., Campos, L. S., Rad, R., Guo, G., Zhang, S., Bradley, A., and Liu, P. (2011) Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1. Proc. Natl. Acad. Sci. U. S. A. 108, 18283-18288.
57. Tonelli, F. M., Santos, A. K., Gomes, D. A., da Silva, S. L., Gomes, K. N., Ladeira, L. O., and Resende, R. R. (2012) Stem cells and calcium signaling. Adv. Exp. Med. Biol. 740, 891-916.
58. Lyssiotis, C. A., Foreman, R. K., Staerk, J., Garcia, M., Mathur, D., Markoulaki, S., Hanna, J., Lairson, L. L., Charette, B. D., Bouchez, L. C., Bollong, M., Kunick, C., Brinker, A., Cho, C. Y., Schultz, P. G., and Jaenisch, R. (2009) Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc. Natl. Acad. Sci. U. S. A. 106, 8912-8917.
59. Knockaert, M., Wieking, K., Schmitt, S., Leost, M., Grant, K. M., Mottram, J. C., Kunick, C., and Meijer, L. (2002) Intracellular targets of paullones. Identification following affinity purification on immobilized inhibitor. J. Biol. Chem. 277, 25493-25501. (Pubitemid 34951864)
60. Bird, A. (2007) Perceptions of epigenetics. Nature 447, 396-398. (Pubitemid 46816744)
61. Reik, W. (2007) Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447, 425-432. (Pubitemid 46816749)
62. Mikkelsen, T. S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B. E., Jaenisch, R., Lander, E. S., and Meissner, A. (2008) Dissecting direct reprogramming through integrative genomic analysis. Nature 454, 49-55. (Pubitemid 351931978)
63. Kishigami, S., Mizutani, E., Ohta, H., Hikichi, T., Thuan, N. V., Wakayama, S., Bui, H. T., and Wakayama, T. (2006) Significant improvement of mouse cloning technique by treatment with trichostatin A after somatic nuclear transfer. Biochem. Biophys. Res. Commun. 340, 183-189. (Pubitemid 41827663)
64. Shi, Y., Desponts, C., Do, J. T., Hahm, H. S., Scholer, H. R., and Ding, S. (2008) Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3, 568-574.
65. Shi, Y., Do, J. T., Desponts, C., Hahm, H. S., Scholer, H. R., and Ding, S. (2008) A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2, 525-528. (Pubitemid 351729222)
66. Makino, S., Fukuda, K., Miyoshi, S., Konishi, F., Kodama, H., Pan, J., Sano, M., Takahashi, T., Hori, S., Abe, H., Hata, J., Umezawa, A., and Ogawa, S. (1999) Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103, 697-705. (Pubitemid 29122423)
67. Huangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., and Melton, D. A. (2008) Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol. 26, 795-797. (Pubitemid 351961456)
68. Ma, T., Xie, M., Laurent, T., and Ding, S. (2013) Progress in the reprogramming of somatic cells. Circ. Res. 112, 562-574.
69. Hawkins, R. D., Hon, G. C., Lee, L. K., Ngo, Q., Lister, R., Pelizzola, M., Edsall, L. E., Kuan, S., Luu, Y., Klugman, S., Antosiewicz-Bourget, J., Ye, Z., Espinoza, C., Agarwahl, S., Shen, L., Ruotti, V., Wang, W., Stewart, R., Thomson, J. A., Ecker, J. R., and Ren, B. (2010) Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell 6, 479-491.
70. Lee, J., Xia, Y., Son, M. Y., Jin, G., Seol, B., Kim, M. J., Son, M. J., Do, M., Lee, M., Kim, D., Lee, K., and Cho, Y. S. (2012) A novel small molecule facilitates the reprogramming of human somatic cells into a pluripotent state and supports the maintenance of an undifferentiated state of human pluripotent stem cells. Angew. Chem., Int. Ed. 51, 12509-12513.
71. Wolffe, A. P. (2001) Chromatin remodeling: why it is important in cancer. Oncogene 20, 2988-2990. (Pubitemid 32553552)
72. Serrano, L., Vazquez, B. N., and Tischfield, J. (2013) Chromatin structure, pluripotency and differentiation. Exp Biol. Med. (Maywood) 238, 259-270.
73. Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., Plath, K., and Hochedlinger, K. (2007) Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1, 55-70.
74. Yuan, X., Wan, H., Zhao, X., Zhu, S., Zhou, Q., and Ding, S. (2011) Brief report: Combined chemical treatment enables Oct4-induced reprogramming from mouse embryonic fibroblasts. Stem Cells 29, 549-553.
75. Lopez-Munoz, F., and Alamo, C. (2009) Monoaminergic neurotransmission: The history of the discovery of antidepressants from 1950s until today. Curr. Pharm. Des 15, 1563-1586.
76. Blelloch, R., Wang, Z., Meissner, A., Pollard, S., Smith, A., and Jaenisch, R. (2006) Reprogramming efficiency following somatic cell nuclear transfer is influenced by the differentiation and methylation state of the donor nucleus. Stem Cells 24, 2007-2013. (Pubitemid 44477125)
77. Rybouchkin, A., Kato, Y., and Tsunoda, Y. (2006) Role of histone acetylation in reprogramming of somatic nuclei following nuclear transfer. Biol. Reprod. 74, 1083-1089. (Pubitemid 47394287)
78. Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M. J., Ji, H., Ehrlich, L. I., Yabuuchi, A., Takeuchi, A., Cunniff, K. C., Hongguang, H., McKinney-Freeman, S., Naveiras, O., Yoon, T. J., Irizarry, R. A., Jung, N., Seita, J., Hanna, J., Murakami, P., Jaenisch, R., Weissleder, R., Orkin, S. H., Weissman, I. L., Feinberg, A. P., and Daley, G. Q. (2010) Epigenetic memory in induced pluripotent stem cells. Nature 467, 285-290.
79. Kondoh, H., Lleonart, M. E., Nakashima, Y., Yokode, M., Tanaka, M., Bernard, D., Gil, J., and Beach, D. (2007) A high glycolytic flux supports the proliferative potential of murine embryonic stem cells. Antioxid. Redox Signaling 9, 293-299. (Pubitemid 46145978)
80. Prigione, A., Fauler, B., Lurz, R., Lehrach, H., and Adjaye, J. (2010) The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells 28, 721-733.
81. Vander Heiden, M. G., Cantley, L. C., and Thompson, C. B. (2009) Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324, 1029-1033.
82. Yoshida, Y., Takahashi, K., Okita, K., Ichisaka, T., and Yamanaka, S. (2009) Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 5, 237-241.
83. Lee, M. O., Moon, S. H., Jeong, H. C., Yi, J. Y., Lee, T. H., Shim, S. H., Rhee, Y. H., Lee, S. H., Oh, S. J., Lee, M. Y., Han, M. J., Cho, Y. S., Chung, H. M., Kim, K. S., and Cha, H. J. (2013) Inhibition of pluripotent stem cell-derived teratoma formation by small molecules. Proc. Natl. Acad. Sci. U. S. A. 110, E3281-3290.
84. Zhao, R., and Daley, G. Q. (2008) From fibroblasts to iPS cells: induced pluripotency by defined factors. J. Cell. Biochem. 105, 949-955.
85. Gonzalez, F., Georgieva, D., Vanoli, F., Shi, Z. D., Stadtfeld, M., Ludwig, T., Jasin, M., and Huangfu, D. (2013) Homologous recombination DNA repair genes play a critical role in reprogramming to a pluripotent state. Cell. Reprogramming 3, 651-660.
86. Shay, J. W., Pereira-Smith, O. M., and Wright, W. E. (1991) A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res. 196, 33-39. (Pubitemid 121006368)
87. Bond, J. A., Blaydes, J. P., Rowson, J., Haughton, M. F., Smith, J. R., Wynford-Thomas, D., and Wyllie, F. S. (1995) Mutant p53 rescues human diploid cells from senescence without inhibiting the induction of SDI1/WAF1. Cancer Res. 55, 2404-2409.
88. Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., and Peters, G. (1996) Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol. 16, 859-867.
89. Hanna, J., Saha, K., Pando, B., van Zon, J., Lengner, C. J., Creyghton, M. P., van Oudenaarden, A., and Jaenisch, R. (2009) Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462, 595-601.
90. Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., Okita, K., and Yamanaka, S. (2009) Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460, 1132-1135.
91. Marion, R. M., Strati, K., Li, H., Murga, M., Blanco, R., Ortega, S., Fernandez-Capetillo, O., Serrano, M., and Blasco, M. A. (2009) A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460, 1149-1153.
92. Utikal, J., Polo, J. M., Stadtfeld, M., Maherali, N., Kulalert, W., Walsh, R. M., Khalil, A., Rheinwald, J. G., and Hochedlinger, K. (2009) Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature 460, 1145-1148.
93. Zhao, Y., Yin, X., Qin, H., Zhu, F., Liu, H., Yang, W., Zhang, Q., Xiang, C., Hou, P., Song, Z., Liu, Y., Yong, J., Zhang, P., Cai, J., Liu, M., Li, H., Li, Y., Qu, X., Cui, K., Zhang, W., Xiang, T., Wu, Y., Liu, C., Yu, C., Yuan, K., Lou, J., Ding, M., and Deng, H. (2008) Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell 3, 475-479.
94. Esteban, M. A., Wang, T., Qin, B., Yang, J., Qin, D., Cai, J., Li, W., Weng, Z., Chen, J., Ni, S., Chen, K., Li, Y., Liu, X., Xu, J., Zhang, S., Li, F., He, W., Labuda, K., Song, Y., Peterbauer, A., Wolbank, S., Redl, H., Zhong, M., Cai, D., Zeng, L., and Pei, D. (2010) Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6, 71-79.
95. Bitler, B. G., Fink, L. S., Wei, Z., Peterson, J. R., and Zhang, R. (2013) A high-content screening assay for small-molecule modulators of oncogene-induced senescence. J. Biomol. Screening 18, 1054-1061.
96. Rhim, J. H., Jang, I. S., Song, K. Y., Ha, M. K., Cho, S. C., Yeo, E. J., and Park, S. C. (2008) Lysophosphatidic acid and adenylyl cyclase inhibitor increase proliferation of senescent human diploid fibroblasts by inhibiting adenosine monophosphate-Activated protein kinase. Rejuvenation Res. 11, 781-792.
97. Ladewig, J., Koch, P., and Brustle, O. (2013) Leveling Waddington: The emergence of direct programming and the loss of cell fate hierarchies. Nat. Rev. Mol. Cell Biol. 14, 225-236.
98. Davis, R. L., Weintraub, H., and Lassar, A. B. (1987) Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51, 987-1000.
99. Kim, W. H., Jung, D. W., Kim, J., Im, S. H., Hwang, S. Y., and Williams, D. R. (2012) Small molecules that recapitulate the early steps of urodele amphibian limb regeneration and confer multipotency. ACS Chem. Biol. 7, 732-743.
100. Anastasia, L., Sampaolesi, M., Papini, N., Oleari, D., Lamorte, G., Tringali, C., Monti, E., Galli, D., Tettamanti, G., Cossu, G., and Venerando, B. (2006) Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle. Cell Death Differ. 13, 2042-2051. (Pubitemid 44742687)
101. Taylor, S. M., and Jones, P. A. (1979) Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-Azacytidine. Cell 17, 771-779. (Pubitemid 9252286)
102. Efe, J. A., Hilcove, S., Kim, J., Zhou, H., Ouyang, K., Wang, G., Chen, J., and Ding, S. (2011) Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat. Cell Biol. 13, 215-222.
103. Sinha, A., Khadilkar, R. J., S, V. K., Roychowdhury Sinha, A., and Inamdar, M. S. (2013) Conserved regulation of the Jak/STAT pathway by the endosomal protein asrij maintains stem cell potency. Cell. Reprogramming 4, 649-658.
104. Wu, H., Wu, Y., Ai, Z., Yang, L., Gao, Y., Du, J., Guo, Z., and Zhang, Y. (2013) Vitamin C enhances nanog expression via activation of the JAK/STAT signaling pathway. Stem Cells, DOI: 10.1002/stem.1523.
105. Ieda, M., Fu, J. D., Delgado-Olguin, P., Vedantham, V., Hayashi, Y., Bruneau, B. G., and Srivastava, D. (2010) Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375-386.
106. Liu, J., Liu, Y., Wang, H., Hao, H., Han, Q., Shen, J., Shi, J., Li, C., Mu, Y., and Han, W. (2013) Direct differentiation of hepatic stem-like WB cells into insulin-producing cells using small molecules. Sci. Rep. 3, 1185.
107. Margariti, A., Winkler, B., Karamariti, E., Zampetaki, A., Tsai, T. N., Baban, D., Ragoussis, J., Huang, Y., Han, J. D., Zeng, L., Hu, Y., and Xu, Q. (2012) Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels. Proc. Natl. Acad. Sci. U. S. A. 109, 13793-13798.
108. Li, J., Huang, N. F., Zou, J., Laurent, T. J., Lee, J. C., Okogbaa, J., Cooke, J. P., and Ding, S. (2013) Conversion of human fibroblasts to functional endothelial cells by defined factors. Arterioscler., Thromb., Vasc. Biol.. 33, 1366-1375.
109. Alexanian, A. R., Liu, Q. S., and Zhang, Z. (2013) Enhancing the efficiency of direct reprogramming of human mesenchymal stem cells into mature neuronal-like cells with the combination of small molecule modulators of chromatin modifying enzymes, SMAD signaling and cyclic adenosine monophosphate levels. Int. J. Biochem. Cell Biol. 45, 1633-1638.
110. Zhao, T., Zhang, Z. N., Rong, Z., and Xu, Y. (2011) Immunogenicity of induced pluripotent stem cells. Nature 474, 212-215.
111. Santaguida, S., Tighe, A., DAlise, A. M., Taylor, S. S., and Musacchio, A. (2010) Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine. J. Cell Biol. 190, 73-87.
112. Ladewig, J., Mertens, J., Kesavan, J., Doerr, J., Poppe, D., Glaue, F., Herms, S., Wernet, P., Kogler, G., Muller, F. J., Koch, P., and Brustle, O. (2012) Small molecules enable highly efficient neuronal conversion of human fibroblasts. Nat. Methods 9, 575-578.
113. Liu, W., Wen, Y., Bi, P., Lai, X., Liu, X. S., Liu, X., and Kuang, S. (2012) Hypoxia promotes satellite cell self-renewal and enhances the efficiency of myoblast transplantation. Development 139, 2857-2865.